IndraLab

Statements

Gefitinib activates EIF3H. 1 / 1

| 1

reach

"Based on these premises, we evaluated MYC and EIF3H gene status in patients with NSCLC treated with the EGFR-TKI gefitinib."

19204574

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Gefitinib activates EIF3H. 1 / 1

INDRA sources:

Databases

Reading